AssetMark’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $74.3K | Buy |
119
+4
| +3% | +$2.34K | ﹤0.01% | 1743 |
|
|
2026
Q2 | $60.9K | Sell |
115
-3
| -3% | -$1.38K | ﹤0.01% | 1770 |
|
|
2026
Q1 | $56.7K | Sell |
118
-52
| -31% | -$26.6K | ﹤0.01% | 1717 |
|
|
2025
Q4 | $95.5K | Sell |
170
-44
| -21% | -$25K | ﹤0.01% | 1506 |
|
|
2025
Q3 | $110K | Sell |
214
-18
| -8% | -$7.86K | ﹤0.01% | 1411 |
|
|
2025
Q2 | $72.8K | Buy |
232
+16
| +7% | +$4.8K | ﹤0.01% | 1440 |
|
|
2025
Q1 | $65.8K | Buy |
216
+43
| +25% | +$14.5K | ﹤0.01% | 1370 |
|
|
2024
Q4 | $57.5K | Buy |
173
+29
| +20% | +$9.8K | ﹤0.01% | 1393 |
|
|
2024
Q3 | $48.1K | Sell |
144
-43
| -23% | -$16.3K | ﹤0.01% | 1299 |
|
|
2024
Q2 | $77K | Buy |
187
+11
| +6% | +$4.36K | ﹤0.01% | 1149 |
|
|
2024
Q1 | $71.1K | Sell |
176
-44
| -20% | -$15.5K | ﹤0.01% | 1100 |
|
|
2023
Q4 | $67.4K | Hold |
220
| – | – | ﹤0.01% | 1101 |
|
|
2023
Q3 | $53.3K | Hold |
220
| – | – | ﹤0.01% | 1084 |
|
|
2023
Q2 | $52.8K | Hold |
220
| – | – | ﹤0.01% | 1059 |
|
|
2023
Q1 | $41.4K | Hold |
220
| – | – | ﹤0.01% | 1075 |
|
|
2022
Q4 | $46.7K | Hold |
220
| – | – | ﹤0.01% | 1057 |
|
|
2022
Q3 | $35K | Sell |
220
-105
| -32% | -$16.8K | ﹤0.01% | 1020 |
|
|
2022
Q2 | $49K | Sell |
325
-85
| -21% | -$12.3K | ﹤0.01% | 918 |
|
|
2022
Q1 | $67K | Hold |
410
| – | – | ﹤0.01% | 860 |
|
|
2021
Q4 | $89K | Sell |
410
-16
| -4% | -$3.35K | ﹤0.01% | 808 |
|
|
2021
Q3 | $81K | Hold |
426
| – | – | ﹤0.01% | 689 |
|
|
2021
Q2 | $75K | Buy |
426
+10
| +2% | +$1.73K | ﹤0.01% | 689 |
|
|
2021
Q1 | $68K | Buy |
416
+50
| +14% | +$7.65K | ﹤0.01% | 685 |
|
|
2020
Q4 | $51K | Buy |
366
+361
| +7,220% | +$45.5K | ﹤0.01% | 710 |
|
|
2020
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 1250 |
|
|
2020
Q2 | $0 | Sell |
5
-2
| -29% | -$170 | ﹤0.01% | 1378 |
|
|
2020
Q1 | $1K | Sell |
7
-24
| -77% | -$2.08K | ﹤0.01% | 1273 |
|
|
2019
Q4 | $3K | Buy |
31
+2
| +7% | +$155 | ﹤0.01% | 1185 |
|
|
2019
Q3 | $2K | Buy |
29
+19
| +190% | +$1.44K | ﹤0.01% | 1174 |
|
|
2019
Q2 | $1K | Buy |
10
+4
| +67% | +$231 | ﹤0.01% | 1250 |
|
|
2019
Q1 | $0 | Buy |
+6
| New | +$358 | ﹤0.01% | 1453 |
|
Other funds holding MEDP
AssetMark's MEDP Position: Q3 2026 in Review
AssetMark increased its Medpace (MEDP) stake by 3.5% in Q3 2026, buying an estimated $2.34K and bringing the position to 119 shares worth $74.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1743.
AssetMark first reported a position in MEDP in Q1 2019 and has held it in 31 quarters since. The position peaked at $110K in Q3 2025. 630 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.
- AssetMark held 119 shares of Medpace worth $74.3K as of Q3 2026.
- AssetMark bought 4 Medpace shares in Q3 2026, an estimated $2.34K.
- Medpace made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1743 holding.
- AssetMark first reported a position in Medpace in Q1 2019 and has held it in 31 quarters since.
- AssetMark's Medpace position peaked at $110K in Q3 2025.
- 630 funds tracked by Wall St. Rank held Medpace as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.